Scott B. Willoughby Sangamo Therapeutics, Inc (SGMO) insider trading activity

Scott B. Willoughby is SVP, GEN. COUNSEL & SECRETARY of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 833,694 shares of SGMO, which is worth approximately $375,162. The most recent transaction as insider was on May 25, 2024, when has been sold 1,336 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $801. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 834K

0.33% 3M change

565.44% 12M change

Total Value Held $375,162

Scott B. Willoughby Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 25 2024	SELL Payment of exercise price or tax liability	$801 $0.6 p/Share	1,336 Reduced 0.16%	833,694 Common Stock
May 24 2024	SELL Payment of exercise price or tax liability	$840 $0.6 p/Share	1,400 Reduced 0.17%	835,030 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$3,901 $1.13 p/Share	3,453 Reduced 0.41%	836,430 Common Stock
Feb 24 2024	SELL Payment of exercise price or tax liability	$4,948 $1.13 p/Share	4,379 Reduced 0.52%	839,883 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	712,500 Added 45.77%	844,262 Common Stock
Nov 25 2023	SELL Payment of exercise price or tax liability	$505 $0.38 p/Share	1,329 Reduced 1.04%	126,762 Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$1,023 $0.77 p/Share	1,329 Reduced 1.03%	128,091 Common Stock

Aug 13 2023	SELL Payment of exercise price or tax liability	$933 $1.08 p/Share	864 Reduced 0.66%	129,420 Common Stock
May 25 2023	SELL Payment of exercise price or tax liability	$1,766 $1.33 p/Share	1,328 Reduced 1.05%	125,284 Common Stock
Apr 24 2023	SELL Payment of exercise price or tax liability	$6,562 $1.65 p/Share	3,977 Reduced 3.05%	126,612 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$13,640 $2.66 p/Share	5,128 Reduced 3.78%	130,589 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	42,750 Added 23.95%	135,717 Common Stock
Aug 13 2022	SELL Payment of exercise price or tax liability	$5,469 $6.33 p/Share	864 Reduced 0.92%	92,966 Common Stock
Apr 29 2022	SELL Payment of exercise price or tax liability	$581 $4.15 p/Share	140 Reduced 0.15%	90,709 Common Stock
Apr 24 2022	SELL Payment of exercise price or tax liability	$18,687 $4.7 p/Share	3,976 Reduced 4.19%	90,849 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$9,239 $5.9 p/Share	1,566 Reduced 2.83%	53,825 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	41,000 Added 30.19%	94,825 Common Stock
Oct 29 2021	SELL Payment of exercise price or tax liability	$1,137 $8.12 p/Share	140 Reduced 0.26%	54,455 Common Stock
Aug 13 2021	BUY Grant, award, or other acquisition	-	7,500 Added 12.08%	54,595 Common Stock

SBW

Scott B. Willoughby

SVP, GEN. COUNSEL & SECRETARY

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Value

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO

Account